Benzinga | Mar 15, 2021 07:18AM EDT

Cyclacel To Present At Oppenheimer 31st Annual Healthcare Conference Mar. 18 At 9:20 a.m. ET

BERKELEY HEIGHTS, N.J., March 15, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, &quot, , Cyclacel&quot, , or the &quot, , Company&quot, , ))))), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the Company will present at the Oppenheimer 31st Annual Healthcare Conference, a virtual event, on Thursday, March 18, 2021 at 9:20 AM (EDT). Spiro Rombotis, President & Chief Executive Officer, will provide an overview of the Company and progress in key programs. Cyclacel will host one-on-one meetings with investors during the event.



A live webcast of the presentation will be available through the Company's website: www.cyclacel.com. The webcast will be archived for 90 days.